1. Parathyroidectomy Is Associated With Reversed Nondipping Heart Rate That Impacts Mortality in Chronic Kidney Disease Patients
- Author
-
Ying Cui, Xueyan Gao, Guang Yang, Jing Zhang, Chun Ouyang, Jing Guo, Shaowen Tang, Ying Xu, Wenbin Zhou, Zhanhui Gao, Hanyang Qian, Yaoyu Huang, Hui Huang, Fangyan Xu, Jing Wang, Lina Zhang, Changying Xing, Ming Zeng, Xiaoming Zha, Yongyue Wei, Ningning Wang, and Wenkai Ren
- Subjects
Parathyroidectomy ,medicine.medical_specialty ,medicine.drug_class ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,030209 endocrinology & metabolism ,Calcium channel blocker ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Heart Rate ,Internal medicine ,Heart rate ,medicine ,Humans ,030212 general & internal medicine ,Circadian rhythm ,Renal Insufficiency, Chronic ,business.industry ,General Medicine ,medicine.disease ,Blood pressure ,Parathyroid Hormone ,Case-Control Studies ,Kidney Failure, Chronic ,Hyperparathyroidism, Secondary ,Secondary hyperparathyroidism ,business ,Body mass index ,Kidney disease - Abstract
Nondipping heart rate (HR), defined as a night/day HR ratio0.90, has been associated with increased mortality in epidemiologic studies. However, its prognostic value in stage 5 chronic kidney disease (CKD5) patients and the effects of parathyroidectomy (PTX) on nondipping HR remain unknown.This case-control study of 162 healthy controls and 502 CKD5 patients was performed between 2011 and 2018, in which CKD5 patients were further divided into non-PTX (n = 186) and severe secondary hyperparathyroidism (SHPT) with PTX (n = 316) subgroups. Each participant underwent 24-hour Holter monitoring for HR ratio. Mortality was followed up in CKD5 patients (median time: 46.0 months).The HR ratio in CKD5 patients was higher than in controls (0.92 ± 0.08 vs 0.81 ± 0.08, P.001), associated with a 44% increase in mortality risk per 0.1 increment (hazard ratio, 1.44; 95% CI: 1.02-2.03; P =.04), and was positively related to serum intact parathyroid hormone levels (P.001). PTX reversed nondipping HR in SHPT patients (n = 50, median time: 6.3 months, P.001). Survival probabilities for PTX (n = 294) were better than non-PTX (n = 47) (hazard ratio, 0.31; 95% CI: 0.14-0.67; P.01) in SHPT patients (serum intact parathyroid hormone500.0 pg/mL).CKD5 patients displayed a nondipping HR pattern, which is a prognostic marker of all-cause mortality. PTX for SHPT patients was associated with a reversal in nondipping HR ratio, which may mediate a better outcome.
- Published
- 2022